MDR-652

N/A

Report date: 2025/01/26 17:22:21
NME

Base Information

Drug NameMDR-652
Drug Alias NameTRPV1 agonists (Medifron)MDR-652
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor agonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedifron
China Registration ClassN/A

Develop Information

Active CompaniesMedifron
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A